Evaluation of serum oxidant/antioxidant balance in multiple sclerosis

Acta Neurologica Belgica

Volumn 112, Issue 3, 2012, Pages 275-280

  Acar, Abdullah ^a   Ugur Cevik, M ^a   Evliyaoglu, Osman ^a   Uzar, Ertugrul ^a   Tamam, Yusuf ^a   Arıkanoglu, Adalet ^a   Yucel, Yavuz ^a   Varol, Sefer ^a   Onder, Hakan ^a   Taşdemir, Nebahat ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Multiple sclerosis; Oxidative stress index; Pathogenesis; Total antioxidant status; Total oxidant status

Indexed keywords

FERRIC ION; MALONALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MALE; METABOLIC BALANCE; MULTIPLE SCLEROSIS; ONSET AGE; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; TOTAL OXIDATIVE STATUS TOTAL ANTIOXIDATIVE STATUS;

EID: 84866118114     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-012-0059-4     Document Type: Article

References (35)

1. Furlan R, Rovaris M, Martinelli Boneschi F, Khademi M, Bergami A, Gironi M, Deleidi M, Agosta F, Franciotta D, Scarpini E, Uccelli A, Zaffaroni M, Kurne A, Comi G, Olsson T, Filippi M, Martino G (2005) Immunological patterns identifying disease course and evolution in multiple sclerosis patients. J Neuroimmunol 165: 192-200.
2. Haider L, Fischer MT, Frischer JM, Bauer J, Höftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H (2011) Oxidative damage in multiple sclerosis lesions. Brain 134: 1914-1924.
3. Miller E, Mrowicka M, Malinowska K, Mrowicki J, Saluk-Juszczak J, Ke{ogonek}dziora J (2011) Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients. World J Biol Psychiatry 12: 223-227.
4. Lutskii MA, Esaulenko IE (2007) Oxidant stress in the pathogenesis of multiple sclerosis. Neurosci Behav Physiol 37: 209-213.
5. Ferretti G, Bacchetti T, Principi F, Di Ludovico F, Viti B, Angeleri VA, Danni M, Provinciali L (2005) Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler 11: 677-682.
6. Uzar E, Koyuncuoglu HR, Uz E, Yilmaz HR, Kutluhan S, Kilbas S, Gultekin F (2006) The activities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 291: 63-68.
7. Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38: 1103-1111.
8. Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37: 277-285.
9. Alp R, Selek S, Alp SI, Taşkin A, Koçyiǧit A (2010) Oxidative and antioxidative balance in patients of migraine. Eur Rev Med Pharmacol Sci 14: 877-882.
10. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
11. Fridovich I (1974) Superoxide dismutase. Adv Enzymol Relat Areas Mol Biol 41: 35-97.
12. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
13. Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36: 1440-1443.
14. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B (1993) Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 121: 257-262.
15. Schreibelt G, van Horssen J, van Rossum S, Dijkstra CD, Drukarch B, de Vries HE (2007) Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev 56: 322-330.
16. Mirshafiey A, Mohsenzadegan M (2009) Antioxidant therapy in multiple sclerosis. Immunopharmacol Immunotoxicol 31: 13-29.
17. Besler HT, Comoǧlu S (2003) Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci 6: 189-196.
18. Koch M, Mostert J, Arutjunyan AV, Stepanov M, Teelken A, Heersema D, De Keyser J (2007) Plasma lipid peroxidation and progression of disability in multiple sclerosis. Eur J Neurol 14: 529-533.
19. Besler HT, Comoǧlu S, Okçu Z (2002) Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr Neurosci 5: 215-220.
20. Ortiz GG, Macías-Islas MA, Pacheco-Moisés FP, Cruz-Ramos JA, Sustersik S, Barba EA, Aguayo A (2009) Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis. Dis Markers 26: 35-39.
21. Koch M, Ramsaransing GS, Arutjunyan AV, Stepanov M, Teelken A, Heersema DJ, De Keyser J (2006) Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. J Neurol 253: 483-487.
22. Mitosek-Szewczyk K, Gordon-Krajcer W, Walendzik P, Stelmasiak Z (2010) Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy. Folia Neuropathol 48: 116-122.
23. Kurban S, Akpi{dotless}nar Z, Mehmetoǧlu I (2010) Investigation of serum paraoxonase and arylesterase activities and oxidative stress in patients with multiple sclerosis. Genel Ti{dotless}p Derg (Turkish) 20: 13-18.
24. Guerrero AL, Gutiérrez F, Iglesias F, Martín-Polo J, Merino S, Martín-Serradilla JI, Laherrán E, Tejero MA (2011) Serum uric acid levels in multiple sclerosis patients inversely correlate with disability. Neurol Sci 32: 347-350.
25. Syburra C, Passi S (1999) Oxidative stress in patients with multiple sclerosis. Ukr Biokhim Zh 71: 112-115.
26. Choi IY, Lee SP, Denney DR, Lynch SG (2011) Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T. Mult Scler 17: 289-296.
27. Ghabaee M, Jabedari B, Al-E-Eshagh N, Ghaffarpour M, Asadi F (2010) Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients. Int J Neurosci 120: 301-304.
28. Johnson F, Giulivi C (2005) Superoxide dismutases and their impact upon human health. Mol Aspects Med 26: 340-352.
29. Singh BK, Kumar A, Ahmad I, Kumar V, Patel DK, Jain SK, Singh C (2011) Oxidative stress in zinc-induced dopaminergic neurodegeneration: implications of superoxide dismutase and heme oxygenase-1. Free Radic Res 45: 1207-1222.
30. Tajouri L, Mellick AS, Ashton KJ, Tannenberg AE, Nagra RM, Tourtellotte WW, Griffiths LR (2003) Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res Mol Brain Res 119: 170-183.
31. Koch M, Mostert J, Arutjunyan A, Stepanov M, Teelken A, Heersema D, De Keyser J (2008) Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis. Mult Scler 14: 159-165.
32. 3 -) levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurol Sci 153: 32-34.
33. Brundin L, Morcos E, Olsson T, Wiklund NP, Andersson M (1999) Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker. Eur J Neurol 6: 585-590.
34. de Bustos F, Navarro JA, de Andrés C, Molina JA, Jiménez-Jiménez FJ, Ortí-Pareja M, Gasalla T, Tallón-Barranco A, Martínez-Salio A, Arenas J (1999) Cerebrospinal fluid nitrate levels in patients with multiple sclerosis. Eur Neurol 41: 44-47.
35. Ikeda M, Sato I, Matsunaga T, Takahashi M, Yuasa T, Murota S (1995) Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome. Int Med 34: 734-737.